Muhammad Furqan, MD
Disclosures: Advisory; -Jazz Pharmaceuticals -Advisory; -Mirat Therapeutics -Advisory; -Abbvie -Advisory; -AstraZeneca Pharmaceuticals LP -Advisory; -Beigene -Advisory; -Janssen Pharmaceutica -Advisory; -Abbvie -Advisory; -AstraZeneca Pharmaceuticals LP -Advisory; -Beigene -Advisory; -Janssen Pharmaceutica -Advisory; -Mirat Therapeutics -Advisory; Helping in reviewing data; -Novartis -AbbVie, Inc.; Altor BioScience, LLC; Amgen, Inc.; Aprea Therapeutics; AstraZeneca LP; AstraZeneca Pharmaceuticals LP; BeiGene, Ltd.; Bristol-Myers Squibb Company; Celgene Corporation; Checkmate Pharmaceuticals; Elicio Therapeutics, Inc.; FATE Therapeutics; Genmab US Inc.; Gilead Sciences, Inc.; Incyte Corporation; Inhibrx, Inc.; Merck Sharp & Dohme LLC; Mirati Therapeutics, Inc; Novartis Pharmaceuticals Corporation; Pharmaceutical Research Associates; PPD Investigator Services, LLC; SOPHiA GENETICS; -Sponsored Research - 10/05/2022
No Bio Available.